SAN DIEGO, Dec. 15, 2025 /PRNewswire/ -- Kenai Therapeutics, a clinical-stage biotechnology company pioneering next generation approaches to cure neurological conditions, today announced that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback